Skip to main content
STRIDES PHARMA SCIENCE LIMITED logo

STRIDES PHARMA SCIENCE LIMITED — Investor Relations & Filings

Ticker · STAR ISIN · INE939A01011 LEI · 335800WHFYXUCHR9DD10 BSE.NS Manufacturing
Open in API
Filings indexed 1,204 across all filing types
Latest filing 2020-08-20 AGM Information
Country IN India
Listing BSE.NS STAR

About STRIDES PHARMA SCIENCE LIMITED

https://www.strides.com

Strides Pharma Science Limited is a global pharmaceutical organization focused on the development and manufacture of IP-led niche finished dosage formulations. The company’s product portfolio encompasses a wide range of therapeutic areas, specializing in complex oral solids, softgel capsules, topicals, and liquids. It maintains a significant presence in highly regulated markets, including the United States, Europe, and Australia, while also serving institutional and emerging markets. The company operates multiple manufacturing facilities globally, many of which are approved by major international regulatory agencies such as the USFDA. Strides emphasizes research and development to drive innovation in specialized delivery systems and difficult-to-manufacture products, positioning itself as a key player in the global generic pharmaceutical landscape.

Recent filings

Filing Released Lang Actions
Shareholders meeting
AGM Information Classification · 95% confidence The document is a detailed summary of the proceedings of the 29th Annual General Meeting (AGM) of Strides Pharma Science Limited held on August 20, 2020. It includes information about the meeting attendees, the agenda items discussed, resolutions passed, and voting procedures. The document specifically mentions it is a 'summary of proceedings of the AGM' and includes details typical of AGM materials such as shareholder questions, presentations by management, and resolutions. There is no indication that this is the full annual report or financial statements, nor is it an announcement of voting results or a proxy solicitation. The content aligns with the category of AGM Information, which covers presentations and materials shared during the AGM. The document length (8130 characters) and detailed content support this classification with high confidence.
2020-08-20 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing the successful completion of a UK MHRA inspection at the company's Puducherry facility and the renewal of the GMP certificate. It is a public communication about a regulatory inspection outcome, not a detailed financial report, audit report, or management discussion. The document is relatively short (3812 characters) and serves as an announcement rather than a comprehensive report. It does not contain financial statements, voting results, or detailed governance information. Therefore, it fits best under the category of a Regulatory Filing (RNS), which is a general category for regulatory announcements and compliance-related communications that do not fit other specific categories.
2020-08-19 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding a newspaper advertisement about a notice of hearing of a petition filed before the National Company Law Tribunal for sanction of a Scheme of Amalgamation. It references SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides information about the hearing date. The document is short (1647 characters) and serves as an announcement or notification rather than a detailed report or filing. It does not contain financial data, management discussion, or detailed legal proceedings information, but rather informs about a legal hearing notice publication. This fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2020-08-11 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the publication of an extract of unaudited financial results for the quarter ended June 30, 2020. It references Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and encloses a newspaper advertisement with the extract. The document itself is short (1515 characters) and primarily serves as a notification or announcement of the financial results publication rather than containing the full financial report or detailed financial data. Therefore, it is not an Interim/Quarterly Report (IR) but rather a Regulatory Filing (RNS) as it is a formal announcement related to regulatory compliance and disclosure of financial results extracts.
2020-08-06 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 100% confidence The document is a letter addressed to stock exchanges announcing the allotment of shares under an employee stock option plan (ESOP). It details the number of shares allotted, the increase in paid-up share capital, and confirms that the new shares rank pari passu with existing shares. There is no financial report, earnings data, or management discussion. The document is an announcement of a capital change due to share allotment under ESOP. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is short and it is not a report publication or certification, so SHA is appropriate.
2020-08-05 English
Financial Result Updates
Regulatory Filings
2020-08-05 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.